Monthly Archive: March 2012

1

BIO CEO: IPR System Threatens Medical Innovation

BIO CEO: IPR System Threatens Medical Innovation In an article published earlier this fall on Medium, Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood urges Congress to modify the inter partes review (IPR)...

1

RMBS Class Action Against Deutsche Bank Dismissed

RMBS Class Action Against Deutsche Bank Dismissed On December 18, Deutsche Bank was dismissed from an RMBS action brought by the New Jersey Carpenters Health Fund regarding certificates backed by RALI and HarborView trusts....

0

New FINRA Supervision Rules May Require Immediate Action

New FINRA Supervision Rules May Require Immediate Action The SEC approved FINRA’s major reworking of its rules governing broker-dealers firms’ supervision of their offices and associated persons. Firms must comply with the new rules...